07:00 , Jul 19, 2010 |  BC Week In Review  |  Clinical News

Artiss regulatory update

Manufacturers of fibrin sealants updated their product labels to emphasize the risk of air embolism and the need to use recommended pressure and distance ranges after reports of adverse events occurring during or after application...
07:00 , Mar 24, 2008 |  BC Week In Review  |  Clinical News

Artiss regulatory update

FDA approved Baxter's Artiss slow-setting fibrin sealant for use in adhering autologous skin grafts in adult and pediatric burn patients. Artiss is an active sealant consisting of human fibrinogen and low concentration human thrombin. Baxter...
07:00 , Mar 24, 2008 |  BC Week In Review  |  Clinical News

Artiss: Phase III data

In a Phase III trial in 138 burn patients requiring wound excision and skin grafting, Artiss was non-inferior to staples on the primary endpoint of complete wound closure at day 28, as measured by planimetry...